high flow oxygen therapy rate adjusted of lung volumes measured
DrugUse of a technique based on non-contact measurement of lung volumes by depth camera in order to optimise the use of hihg flow oxygen therapy, with adaptation of the flow rate.
NCT Number: NCT06819644
The goal of this clinical trial is to validate the interest of a strategy adjusting the flow rate delivered under high-flow oxygen (HFO) therapy according to the lung volumes measured by a new technique, in intensive care patients with hypoxemic respiratory distress (HRD).
The main question it aims to answer is:
"The use of a technique of measurement of lung pulmonary with adjustement to the flow rate can make it possible to limite intubation in patients with HRD in intensive care?" The participants will be the patients admitted in intensive care for HRD with the need for treatment with HFO.
This participants will be randomized in :
* the arm control: treated by high flow oxygen therapy according to standard procedures. * or in the experimental arm : treated by high flow oxygen therapy with adjustement of ventilatory parametres based on lung volume measurements, obtained by the depth camera.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 3
Brest, University Hospital, Brest, France
High-flow oxygen therapy (HFO) is a common technique for the management of patient with hypoxemic respiratory distress in intensive care.The variations in lung volumes induced by the HFO in patients is unknown in clinical routine, in the absence of the availability of a effective measurement technique.
The investigators research team validated a new non-invasive, non-contact technique for measuring lung volumes using depth camera. Using a stereoscopic camera, the patient's chest and abdomen are recognized by a artificial intelligence algorithms. The structures of interest of the chest and the abdomen are the identified and the variation in depth of these points in space allows both the integration of lung volume through automatic calibration procedures, the measurement of respiratory rate and comparaison of movement symetries.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of a technique based on non-contact measurement of lung volumes by depth camera in order to optimise the use of hihg flow oxygen therapy, with adaptation of the flow rate.
Time frame: from patient randomization to day 90
Collection of the use of intubation (Yes/No) in patients
Time frame: up to 28 days after randomization
daily SOFA score
Time frame: up to 28 days after randomization
daily ROX Index
Time frame: from inclusion to day 28
Number of days without ventilatory support
Time frame: 90 days after inclusion
Number of death
Time frame: from patient inclusion to day 90
Evaluation of ergonomy by the System Usability Scale (SUS). The SUS is based on a Likert scale that allows the user to respond on a 5-point scale from 1:'Strongly disagree' to 5:'Strongly agree'.
Time frame: from patient inclusion to day 90
Evaluation of load task by NASA-TLX index
Time frame: up to 28 days after randomization
EVA scale
Contact information is provided by the study sponsor or research team.
University Hospital, Brest
Other
Acronym: DiStok
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07322133
Cardiovascular Diseases, Hypertension
Sacramento, California, United States
View Trial DetailsNCT05089695
Hypoxemic Respiratory Failure, Respiration Disorders
Rome, Italy
View Trial DetailsNCT06716463
Hypoventilation, Hypoxemic Respiratory Failure
Toronto, Ontario, Canada
View Trial DetailsNCT07714564
Hypoxemic Respiratory Failure, Mechanical Ventilation
Rome, Italy
View Trial Details